It has already been two or three months since the incident occurred, yet Shenzhen Securities Information Co., Ltd. still has not issued any explanation regarding the matter of TRANSTHERA-B's inclusion in the index.

At the time when TRANSTHERA-B was included in the index, it caused a stir in the news. A reporter interviewed the index compiler, Shenzhen Securities Information Co., Ltd., and a staff member replied that the matter was under study and that the company would provide a response later.

Now, two or three months have passed, and with only one day left before 2025 concludes, where is this explanation from Shenzhen Securities Information Co., Ltd.? I haven't seen it. I checked the official website, but only found announcements or news about index revisions; I did not see any explanation regarding the TRANSTHERA-B matter.

Will this explanation be delayed until 2026?

As one of the important infrastructures of China's capital markets, the China Securities Index enjoys high market recognition and significant attention. Therefore, it is hoped that Shenzhen Securities Information Co., Ltd. will shoulder its mission and responsibility in the TRANSTHERA-B matter, communicate sincerely with investors, and jointly promote the vigorous development of index investing in China. It is sincerely hoped that this matter will not be dragged into 2026, as there is truly no need for further delay.

As investors, we believe that the China Securities Index and Shenzhen Securities Information Co., Ltd. have their own sense of responsibility, will publicly and directly address this issue, and will not downplay it.

Analysis of the TRANSTHERA-B situation from that time can be viewed here.

Vast amounts of information and precise interpretation are available on the Sina Finance App.